IL6 and Insulin resistance: The combined intervention (EDG) reduced the insulin resistance FG/I (<i>p</i> = 0.02) and atherogenic index CRI II (<i>p</i> = 0.01), decreased inflammatory markers IL-6 (<i>p</i> = 0.01) by 48% and hs-CRP (<i>p</i> = 0.04) by 30%, and simultaneously increased the ADIPO (<i>p</i> = 0.02) concentration by 15%.